DNA Replication Licensing Factors: Novel Targets for Cancer Therapy via Inhibiting the Stemness of Cancer Cells

The replication licensing factors strictly regulate the DNA replication origin licensing process to guarantee the stability of the genome. Numerous experimental studies have recently demonstrated that the replication licensing factors as oncogenes are essential for the occurrence and development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Shaoran, Wang, Yaochun, Liu, Peijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771848/
https://www.ncbi.nlm.nih.gov/pubmed/35173548
http://dx.doi.org/10.7150/ijbs.67529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771848/
https://www.ncbi.nlm.nih.gov/pubmed/35173548
http://dx.doi.org/10.7150/ijbs.67529

Ejemplares similares